IA
LKFT

IFP Advisors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

IFP Advisors’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Hold
0
– – – 3999
2023
Q1 		– Sell
-74
Closed -$8K – 3800
2022
Q4 		$8K Hold
74
– – ﹤0.01% 3516
2022
Q3 		$8K Hold
74
– – ﹤0.01% 3773
2022
Q2 		$8K Hold
74
– – ﹤0.01% 3527
2022
Q1 		$8K Buy
+74
New +$4.53K ﹤0.01% 3526

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

IFP Advisors's LKFT Position: Q4 2024 in Review

IFP Advisors held its Lakefront Biotherapeutics American Depositary Shares (LKFT) position steady in Q4 2024 at 0 shares worth $110. The position accounts for ﹤0.01% of the portfolio, ranked #3999.

IFP Advisors first reported a position in LKFT in Q1 2022 and has held it in 4 quarters since. The position peaked at $8K in Q4 2022. 81 funds tracked by Wall St. Rank hold LKFT as of Q4 2024.

  • IFP Advisors held 0 shares of Lakefront Biotherapeutics American Depositary Shares worth $110 as of Q4 2024.
  • IFP Advisors left its Lakefront Biotherapeutics American Depositary Shares share count unchanged in Q4 2024.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of IFP Advisors's portfolio in Q4 2024, its #3999 holding.
  • IFP Advisors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2022 and has held it in 4 quarters since.
  • IFP Advisors's Lakefront Biotherapeutics American Depositary Shares position peaked at $8K in Q4 2022.
  • 81 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2024.

Based on IFP Advisors's 13F filing for Q4 2024, filed 4 Feb 2025.